Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06734377 · ClinicalTrials.gov registry record · NA
Causal Role of Delta and Theta Oscillations in Hierarchical Cognitive Control
A NA study of Rhythmic Transcranial Magnetic Stimulation (rTMS) Effect on Hierarchical Cognitive Control, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT06734377: Completed NA study of Rhythmic Transcranial Magnetic Stimulation (rTMS) Effect on Hierarchical Cognitive Control, sponsored by Florida State University.
NCT06734377 is a NA study of Rhythmic Transcranial Magnetic Stimulation (rTMS) Effect on Hierarchical Cognitive Control that has completed, run by Florida State University. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06734377, a NA study of Rhythmic Transcranial Magnetic Stimulation (rTMS) Effect on Hierarchical Cognitive Control, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to evaluate the effect of rhythmic transcranial magnetic stimulation (TMS) delivered at delta (2.2 Hz) or theta (6.5 Hz) frequency on cognitive control. This study aims to explore how targeted stimulation at delta and theta frequencies modulates brain activity to enhance cognitive performance in healthy populations.
Primary Outcome
The Accuracy, reflecting the participants' ability to correctly follow task rules and make accurate judgments based on the given stimulus, is calculated as the percentage of correct responses across trials. The value range is 0% (no correct responses) to 100% (all responses correct), with a larger number denoting more correct responses.
Conditions Studied
Interventions
- DEVICE Delta TMS
- DEVICE Theta TMS
- DEVICE Arrhythmic TMS
Study Locations (1)
Florida
- Florida State University Psychology Dept Bldg A411 - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2025-01-20 |
| Est. Completion | 2025-10-17 |
| Phase | NA |
What the finished NCT06734377 record still lists
NCT06734377 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Rhythmic Transcranial Magnetic Stimulation (rTMS) Effect on Hierarchical Cognitive Control appearing as the primary indexed condition, and to 3 interventions - of which Delta TMS is the first listed.
NCT06734377 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06734377 about?
NCT06734377 is a clinical study titled "Causal Role of Delta and Theta Oscillations in Hierarchical Cognitive Control". The purpose of this clinical trial is to evaluate the effect of rhythmic transcranial magnetic stimulation (TMS) delivered at delta (2.2 Hz) or theta (6.5 Hz) frequency on cognitive control. This study aims to explore how targeted stimulation at delta and theta frequencies modulates brain activity ...
What is the current status of trial NCT06734377?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2025-01-20. Estimated completion is 2025-10-17.
What conditions does trial NCT06734377 study?
This clinical trial studies the following conditions: Rhythmic Transcranial Magnetic Stimulation (rTMS) Effect on Hierarchical Cognitive Control.
What interventions are being tested in trial NCT06734377?
The interventions under investigation include: Delta TMS (DEVICE), Theta TMS (DEVICE), Arrhythmic TMS (DEVICE).
Who is sponsoring clinical trial NCT06734377?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06734377 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06734377's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI